| # | Title | Journal | Year | Citations |
|---|
| 1 | Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database | Annals of the Rheumatic Diseases | 2010 | 1,017 |
| 2 | Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis | New England Journal of Medicine | 2015 | 803 |
| 3 | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases | Annals of the Rheumatic Diseases | 2011 | 533 |
| 4 | Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group | Annals of the Rheumatic Diseases | 2016 | 383 |
| 5 | Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension | Journal of Bone and Mineral Research | 2012 | 290 |
| 6 | Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study | Annals of the Rheumatic Diseases | 2018 | 279 |
| 7 | Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) | Annals of the Rheumatic Diseases | 2013 | 259 |
| 8 | Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial | Lancet, The | 2018 | 251 |
| 9 | The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) – an OARSI/OMERACT initiative | Osteoarthritis and Cartilage | 2008 | 219 |
| 10 | Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap | Journal of Rheumatology | 1996 | 219 |
| 11 | Consensus statement on the use of rituximab in patients with rheumatoid arthritis | Annals of the Rheumatic Diseases | 2006 | 194 |
| 12 | The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative | Osteoarthritis and Cartilage | 2008 | 156 |
| 13 | The SFA system for assessing articular cartilage lesions at arthroscopy of the knee | Arthroscopy - Journal of Arthroscopic and Related Surgery | 1994 | 150 |
| 14 | Automated Percutaneous Lumbar Discectomy Versus Chemonucleolysis in the Treatment of Sciatica | Spine | 1993 | 143 |
| 15 | Changes in Bone Density in Patients with Ankylosing Spondylitis: A Two-Year Follow-Up Study | Osteoporosis International | 2001 | 134 |
| 16 | Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study | Bone | 2014 | 133 |
| 17 | Inflammatory diseases and bone fragility | Osteoporosis International | 2017 | 132 |
| 18 | Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis | Journal of Bone and Mineral Research | 2012 | 124 |
| 19 | Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. | Annals of the Rheumatic Diseases | 1988 | 122 |
| 20 | Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms | European Journal of Endocrinology | 2016 | 119 |
| 21 | Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course | Journal of Clinical Medicine | 2019 | 118 |
| 22 | Raynaud phenomenon and digital ulcers in systemic sclerosis | Nature Reviews Rheumatology | 2020 | 115 |
| 23 | The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound | Annals of the Rheumatic Diseases | 2013 | 110 |
| 24 | Osteoporosis, body composition, and bone turnover in ankylosing spondylitis | Journal of Rheumatology | 1999 | 110 |
| 25 | Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD | RMD Open | 2019 | 104 |
| 26 | The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress | Annals of the Rheumatic Diseases | 2011 | 102 |
| 27 | Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions | Annals of the Rheumatic Diseases | 2013 | 102 |
| 28 | The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women | Osteoporosis International | 2005 | 101 |
| 29 | KNEE JOINT SPACE WIDTH MEASUREMENT: AN EXPERIMENTAL STUDY OF THE INFLUENCE OF RADIOGRAPHIC PROCEDURE AND JOINT POSITIONING | Rheumatology | 1996 | 100 |
| 30 | Sonographic Appearance of Trigger Fingers | Journal of Ultrasound in Medicine | 2008 | 96 |
| 31 | Effects of strontium ranelate on spinal osteoarthritis progression | Annals of the Rheumatic Diseases | 2007 | 95 |
| 32 | Bone Turnover and Bone Mineral Density Are Independently Related to Selenium Status in Healthy Euthyroid Postmenopausal Women | Journal of Clinical Endocrinology and Metabolism | 2012 | 91 |
| 33 | Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study | Annals of the Rheumatic Diseases | 2020 | 91 |
| 34 | Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women | Osteoporosis International | 2012 | 86 |
| 35 | Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis | RMD Open | 2015 | 85 |
| 36 | Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis | Annals of the Rheumatic Diseases | 2018 | 85 |
| 37 | Vitamin D deficiency and the COVID-19 pandemic | Journal of Global Antimicrobial Resistance | 2020 | 84 |
| 38 | Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey | Annals of the Rheumatic Diseases | 2018 | 83 |
| 39 | Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement | Annals of the Rheumatic Diseases | 2013 | 80 |
| 40 | Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis | Joint Bone Spine | 2012 | 78 |
| 41 | Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA | Rheumatology | 2017 | 78 |
| 42 | Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial | Lancet, The | 2020 | 78 |
| 43 | Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis | RMD Open | 2019 | 77 |
| 44 | Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis | Annals of the Rheumatic Diseases | 1998 | 76 |
| 45 | Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial | Annals of the Rheumatic Diseases | 2014 | 76 |
| 46 | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study | BMJ: British Medical Journal | 2019 | 76 |
| 47 | Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin | Journal of the American Academy of Dermatology | 1993 | 74 |
| 48 | Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients | Journal of Autoimmunity | 1991 | 72 |
| 49 | Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study | Bone | 2004 | 72 |
| 50 | Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin | Clinical and Experimental Rheumatology | 2010 | 68 |
